A real-world study based on the FAERS database evaluating adverse drug reactions in three amphotericin B lipid formulations
Background: Amphotericin B (AmB) remains the cornerstone in the treatment of severe fungal infections. However, selecting an appropriate lipid-based formulation for different clinical scenarios remains a challenge for clinicians and clinical pharmacists.Methods: Adverse event (AE) reports from the F...
Saved in:
| Main Authors: | Binliang Tong, Jiaqi Wang, Yanjing Zhang, Yan Liu, Jing Wang, Liguang Duan, Yuhang Yan, Qixuan Sun, Yueyao Luan, Jing Yu, Chunhua Zhou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Journal of Pharmaceutical Policy and Practice |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/20523211.2025.2514155 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative efficacy and tolerability of amphotericin B lipid complex and liposomal amphotericin B in the treatment of invasive fungal infections in patients with hematological malignancies: literature review
by: N. V. Dmitrieva, et al.
Published: (2014-07-01) -
Determination of amphotericin B antifungal susceptibility in Candida strains using an inverted microscope
by: Demet Gür Vural, et al.
Published: (2024-02-01) -
Retrobulbar Amphotericin B in Mucormycosis: A Ray of Hope
by: Shalini Mohan, et al.
Published: (2022-01-01) -
Genome analyses of amphotericin B-susceptible and -resistant strains of Leishmania (Mundinia) martiniquensis reveal variations potentially related to amphotericin B resistance
by: Narissara Jariyapan, et al.
Published: (2025-01-01) -
Antifungal effects of andrographolide and its combination with amphotericin B against selected fungal pathogens
by: Gayus Sale Dafur, et al.
Published: (2025-06-01)